BackVBI Vaccines Overview

VBI Vaccines Net Income

Profitability analysis for VBIV.

Quarterly Net Income

-$17.90M
52.17% YoY

As of Mar 2024

Annual Net Income (TTM)

-$82.98M
35.9% YoY

Trailing 12 months ending Mar 2024

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...